Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q4 2025 Earnings

14NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.15

0.19

0.54

0.88

Details

Expected EPS

-0.13

Actual EPS

-0.13

Surprise EPS

0

Surprise Percent

+0%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.13 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.